In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation

Molecular Therapy : the Journal of the American Society of Gene Therapy
Ana M MorenoPrashant Mali

Abstract

Development of efficacious in vivo delivery platforms for CRISPR-Cas9-based epigenome engineering will be critical to enable the ability to target human diseases without permanent modification of the genome. Toward this, we utilized split-Cas9 systems to develop a modular adeno-associated viral (AAV) vector platform for CRISPR-Cas9 delivery to enable the full spectrum of targeted in situ gene regulation functionalities, demonstrating robust transcriptional repression (up to 80%) and activation (up to 6-fold) of target genes in cell culture and mice. We also applied our platform for targeted in vivo gene-repression-mediated gene therapy for retinitis pigmentosa. Specifically, we engineered targeted repression of Nrl, a master regulator of rod photoreceptor determination, and demonstrated Nrl knockdown mediates in situ reprogramming of rod cells into cone-like cells that are resistant to retinitis pigmentosa-specific mutations, with concomitant prevention of secondary cone loss. Furthermore, we benchmarked our results from Nrl knockdown with those from in vivo Nrl knockout via gene editing. Taken together, our AAV-CRISPR-Cas9 platform for in vivo epigenome engineering enables a robust approach to target disease in a genomically s...Continue Reading

Citations

Feb 9, 2019·Biomaterials Science·Joon Eoh, Luo Gu
Apr 5, 2019·Molecular Diagnosis & Therapy·Panayiota PapasavvaCarsten W Lederer
Apr 5, 2019·Molecular Diagnosis & Therapy·Petros PatsaliCarsten W Lederer
Jul 10, 2019·Expert Opinion on Drug Delivery·Ah Young LeeSanghwa Kim
Jan 10, 2020·Human Gene Therapy·Patrizia Tornabene, Ivana Trapani
Mar 4, 2020·International Journal of Molecular Sciences·Emmanuelle ClérinThierry Léveillard
Apr 2, 2020·International Journal of Molecular Sciences·Caroline F PeddleRobert E MacLaren
Dec 11, 2019·Briefings in Functional Genomics·Wen-Di PeiYang Yu
Oct 23, 2019·Clinical and Translational Medicine·Maria Schacker, Diane Seimetz
Dec 21, 2019·Journal of Medical Genetics·Daniela BenatiAlessandra Recchia
Oct 1, 2020·Human Gene Therapy·Joel QuinnKanmin Xue
Sep 5, 2020·Nature Cell Biology·Farzaneh MoghadamSamira Kiani
Dec 27, 2018·International Ophthalmology Clinics·Ninel Z GregoriJanet L Davis
Oct 5, 2018·Transgenic Research·Cia-Hin Lau, Yousin Suh
Feb 8, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Noboru IdenoBidyut Ghosh
Apr 30, 2020·International Journal of Molecular Sciences·Xingbo XuElisabeth M Zeisberg
Aug 1, 2020·Frontiers in Cellular Neuroscience·Lucy S FrenchLivia S Carvalho
Sep 10, 2020·Frontiers in Molecular Neuroscience·Joseph Edward RittinerBoris Kantor
Apr 2, 2020·Nature Biotechnology·Joseph M ReplogleBritt Adamson
Jan 2, 2021·Frontiers in Neuroscience·Michael R Volkert, David J Crowley
Jul 1, 2020·Advanced Drug Delivery Reviews·Wenhan Yu, Zhijian Wu
Jan 6, 2021·Asia-Pacific Journal of Ophthalmology·David XuAllen C Ho
Nov 17, 2020·Frontiers in Neuroscience·Fábio Duarte, Nicole Déglon
May 28, 2019·Trends in Genetics : TIG·J Antonio GomezDavid J Segal
Jan 24, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Helena Costa VerderaFederico Mingozzi
Sep 17, 2020·Science Advances·Sybille BöhmElvir Becirovic
Mar 12, 2021·Science Translational Medicine·Ana M MorenoPrashant Mali
Apr 4, 2021·International Journal of Molecular Sciences·Panayiota L PapasavvaCarsten W Lederer
May 12, 2021·Trends in Biotechnology·Jacob H Goell, Isaac B Hilton
Jun 1, 2021·Progress in Retinal and Eye Research·Catherine BottoDeniz Dalkara
Jul 31, 2021·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Yuanyuan Li, Li-Quan Zhou
Jan 12, 2021·Briefings in Bioinformatics·Hui PengJinyan Li
Sep 30, 2021·International Ophthalmology Clinics·Michael T Massengill, Alfred S Lewin
Oct 19, 2021·Frontiers in Medicine·Jennifer Hernández-JuárezShyamanga Borooah

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Cynthia L MontanaJoseph C Corbo
American Journal of Ophthalmology
G WALD, B H ZEAVIN
© 2022 Meta ULC. All rights reserved